Cited by 621Adipokines, Inflammation, and Metabolic DiseasesAdipose Tissue and MetabolismRegulation of Appetite and Obesity

Physiology and role of irisin in glucose homeostasis

Open access
Perakakis, Nikolaos, Triantafyllou, Georgios A., Fernández-Real, José Manuel, Huh, Joo Young, Park, Kyung Hee, Seufert, Jochen, Mantzoros, Christos S.·2017·Nature Reviews Endocrinology

Abstract

Irisin is a myokine that leads to increased energy expenditure by stimulating the 'browning' of white adipose tissue. In the first description of this hormone, increased levels of circulating irisin, which is cleaved from its precursor fibronectin type III domain-containing protein 5, were associated with improved glucose homeostasis by reducing insulin resistance. Consequently, several studies attempted to characterize the role of irisin in glucose regulation, but contradictory results have been reported, and even the existence of this hormone has been questioned. In this Review, we present the current knowledge on the physiology of irisin and its role in glucose homeostasis. We describe the mechanisms involved in the synthesis, secretion, circulation and regulation of irisin, and the controversies regarding the measurement of irisin. We also discuss the direct effects of irisin on glucose regulatory mechanisms in different organs, the indirect effects and interactions with other hormones, and the important open questions with regard to irisin in those organs. Finally, we present the results from animal interventional studies and from human clinical studies investigating the association of irisin with obesity, insulin resistance, type 2 diabetes mellitus and the metabolic syndrome.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1038/nrendo.2016.221

Cites

138 of 138 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

2 retracted

Flagged first, then by citations

Research works printed but not linked: 3

  1. [5]NCBI Fibronectin type III domain-containing protein 5 precursor [Rattus norvegicus] NCBI https://www.ncbi.nlm.nih.gov/protein/NP_001257910.1 2016
  2. [6]NCBI Fibronectin type III domain-containing protein 5 preproprotein [Mus musculus] NCBI https://www.ncbi.nlm.nih.gov/protein/NP_081678.1 2016
  3. [7]NCBI Fibronectin type III domain-containing protein 5 isoform 2 preproprotein [Homo sapiens] NCBI https://www.ncbi.nlm.nih.gov/protein/NP_715637.2 2016

Cited by

Sorted by citations

Authors
Perakakis, N., Triantafyllou, G. A., Fernández-Real, J. M., Huh, J. Y., Park, K. H., Seufert, J., & Mantzoros, C. S.
Affiliations
  • Beth Israel Deaconess Medical Center (US)
  • Chonnam National University (KR)
  • Hallym University Sacred Heart Hospital (KR)
  • University of Freiburg (DE)
Corresponding author
  • Perakakis, Nikolaos
  • Mantzoros, Christos S.
Venue
Nature Reviews Endocrinology
Published
2017-02-17
Volume
13
Issue
6
Pages
324-337
ISSN
  • 1759-5029 (ISSN-L)
  • 1759-5037
OpenAlex
W2587815451
Cited by
621
References
138
Citations by year
2026: 38 · 2025: 58 · 2024: 81 · 2023: 66 · 2022: 96 · 2021: 92 · 2020: 76 · 2019: 50 · 2018: 44 · 2017: 20
FWCI
6.88
Type
journal article
Language
en
Open access
Locations
  • Nature Reviews Endocrinology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
National Institute of Diabetes and Digestive and Kidney Diseases (K24DK081913)
Topics
  • Health Sciences › Medicine › Epidemiology › Adipokines, Inflammation, and Metabolic Diseases
  • Health Sciences › Medicine › Physiology › Adipose Tissue and Metabolism
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
Keywords
irisin, myokines, glucose homeostasis, insulin resistance, type 2 diabetes, metabolic syndrome, obesity, white adipose tissue browning, energy expenditure
MeSH terms
Adipose Tissue, Animals, Diabetes Mellitus, Type 2, Fibronectins, Glucose, Homeostasis, Humans, Insulin Resistance, Liver, Metabolic Diseases, Obesity, Pancreas, Exercise, Muscle, Skeletal, Metabolic Syndrome

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review